Dudediligence.

Surrozen, Inc

SRZNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Revenue
$11.5Mlast 12 months
Net income
−$332.1Mlast 12 months
Operating cash flow
−$33.5Mlast 12 months
Cash and equivalents
$102.0Mat the last balance sheet
Shares outstanding
11.8M shareson issue
Every year and quarter →